Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9H1H1
UPID:
GTSFL_HUMAN
Alternative names:
Protein FAM112A
Alternative UPACC:
Q9H1H1; Q5JWH5
Background:
Gametocyte-specific factor 1-like, also known as Protein FAM112A, is a protein of interest in the field of biochemistry and molecular biology. Its alternative names and the unique identifier Q9H1H1 provide a basis for scientific research and exploration. The protein's specific functions and interactions within cellular processes remain to be fully elucidated, making it a subject of ongoing investigation.
Therapeutic significance:
Understanding the role of Gametocyte-specific factor 1-like could open doors to potential therapeutic strategies. The exploration of its functions and mechanisms may reveal novel targets for drug discovery, contributing to the advancement of personalized medicine and treatment options.